caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1942388442

Michael MusciMD

PRACTICEIRONWOOD PHYSICIANS, PCSee all providers at this practice →
Hematology-OncologyMesa, AZI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Michael Musci's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 67 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BANNER BAYWOOD MEDICAL CENTER2651,339
Monique Chang
Hematology-Oncology · Mesa, AZ
94708
Mark Ono
Radiation Oncology · Scottsdale, AZ
651,900
Luke Halbur
Hematology-Oncology · Mesa, AZ
60354
Davis Romney
Radiation Oncology · Mesa, AZ
60964
NPI 131699240755163
LONG, MICHAEL51259
SCHIFTER, TOBIAS49119
Andrew Pohl
Diagnostic Radiology · Mesa, AZ
46149
Farukh Mian
Diagnostic Radiology · Maywood, IL
43101
MCCALL, THOMAS39127
Concepcion Roxas
Pathology · Mesa, AZ
38125
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,973
Unique beneficiaries
—
Total services
87,498
Distinct HCPCS
42
Medicare payment
$1.2M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 199 Hematology-Oncology providers in AZ — top quintile (cohort median 31,409).
PRESCRIBING · PART D · 2024
Total Rx claims
1,128
Beneficiaries
—
Total drug cost
$3.5M
Distinct drugs
31
Brand share
42.6%
Top prescribed drugs
Apixaban127 claims
Dexamethasone109 claims
Acyclovir103 claims
Ondansetron94 claims
Prednisone73 claims
QUALITY · MIPS · 2024
Final MIPS score
97.2
Quality
96.0
Cost
56.7
Improvement activities
40.0
Promoting interop.
98.0
Payment adjustment
0.93%
Subgroup
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
112
By payment type
Food and Beverage$2K